Literature DB >> 31834835

ADAM12 controls a hypertrophic response in the heart through the distinct descending pathways.

Yoshinobu Nakayama1, Jun Yoshioka1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31834835      PMCID： PMC7052620          DOI： 10.1152/ajpheart.00704.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  9 in total

1.  Shedding growth factors in cardiac hypertrophy.

Authors:  James K Liao
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 2.  ADAMs family and relatives in cardiovascular physiology and pathology.

Authors:  Pu Zhang; Mengcheng Shen; Carlos Fernandez-Patron; Zamaneh Kassiri
Journal:  J Mol Cell Cardiol       Date:  2015-10-29       Impact factor: 5.000

3.  A disintegrin and metalloproteinase 12 prevents heart failure by regulating cardiac hypertrophy and fibrosis.

Authors:  Yuto Nakamura; Shunbun Kita; Yoshimitsu Tanaka; Shiro Fukuda; Yoshinari Obata; Tomonori Okita; Yusuke Kawachi; Yuri Tsugawa-Shimizu; Yuya Fujishima; Hitoshi Nishizawa; Shigeru Miyagawa; Yoshiki Sawa; Atsuko Sehara-Fujisawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-27       Impact factor: 4.733

4.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.

Authors:  Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

5.  A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.

Authors:  Dong Fan; Abhijit Takawale; Mengcheng Shen; Victor Samokhvalov; Ratnadeep Basu; Vaibhav Patel; Xiuhua Wang; Carlos Fernandez-Patron; John M Seubert; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

6.  Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.

Authors:  Paul W M Fedak; Christine S Moravec; Patrick M McCarthy; Svetlana M Altamentova; Amy P Wong; Marko Skrtic; Subodh Verma; Richard D Weisel; Ren-Ke Li
Journal:  Circulation       Date:  2006-01-09       Impact factor: 29.690

7.  Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine/paracrine heparin-binding EGF.

Authors:  Jun Yoshioka; Robin N Prince; Hayden Huang; Scott B Perkins; Francisco U Cruz; Catherine MacGillivray; Douglas A Lauffenburger; Richard T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

Review 8.  A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems.

Authors:  Jiaxi Xu; Snigdha Mukerjee; Cristiane R A Silva-Alves; Alynne Carvalho-Galvão; Josiane C Cruz; Camille M Balarini; Valdir A Braga; Eric Lazartigues; Maria S França-Silva
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

9.  Guidelines for measuring cardiac physiology in mice.

Authors:  Merry L Lindsey; Zamaneh Kassiri; Jitka A I Virag; Lisandra E de Castro Brás; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.